S&P 500 Financials Sector SEC Filings — June 02, 2026

02-06-2026

Gyre Therapeutics, Inc. filed an 8-K on June 2, 2026, disclosing that it made an updated corporate presentation available on its website on June 1, 2026. The presentation is furnished as Exhibit 99.1 and is not deemed filed for SEC liability purposes. No financial results or material operational updates were provided in the filing itself.

• · The corporate presentation was made available on June 1, 2026.
• · The filing is under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The presentation is not deemed filed for purposes of Section 18 of the Exchange Act.

02-06-2026

At its 2026 Annual General Meeting held on May 29, 2026, Janus Henderson Group plc shareholders approved all five proposals, including the election of 11 director nominees, an increase in the cap on non-executive director compensation, an advisory say-on-pay vote, renewal of share repurchase authority, and auditor reappointment. While most proposals received strong support (over 98% for directors and over 99% for share repurchase and auditor reappointment), the say-on-pay vote received only 66.8% approval, with 33.2% against, indicating notable shareholder dissent on executive compensation.

• · All 11 director nominees were elected with for votes ranging from 96.2% (Kalpana Desai) to 99.8% (Ali Dibadj).
• · Proposal 2 (increase non-executive director compensation cap) passed with 71.7% for, but 28.3% against.
• · Proposal 3 (say-on-pay) passed with only 66.8% for, and 33.2% against, indicating significant shareholder opposition.
• · Proposal 4 (share repurchase authority) and Proposal 5 (auditor reappointment) each received 99.8% for votes.
• · Broker non-votes were 12,800,205 for director elections and Proposals 2 and 3, but zero for Proposals 4 and 5.
• · Issued share capital as of record date April 13, 2026 was 154,075,608 shares.

02-06-2026

Medallion Financial Corp. issued a letter to shareholders on June 1, 2026, disputing Glass Lewis's recommendation to vote against two board nominees. The company highlights that net income before tax from 2021 to 2025 exceeded $378 million, more than the first 25 years combined, and total shareholder return since January 31, 2017 is 452%. However, Glass Lewis's negative stance is based on unproven SEC allegations from a since-settled lawsuit, and the company argues that Glass Lewis has inconsistently applied its standards, ignoring serious allegations against dissident nominee Eric Kelly.

• · Glass Lewis recommended against two board nominees, a shift from its prior four consecutive years of supporting all nominees.
• · The SEC lawsuit was settled in May 2025 without admissions of wrongdoing and without material restrictions on the business.
• · Glass Lewis revised its report after Medallion pointed out mischaracterizations, but Medallion says the revised report remains misleading.
• · Eric Kelly, a dissident nominee supported by Glass Lewis, is a defendant in a wrongful termination lawsuit alleging GAAP violations, tax avoidance, and improper financial practices; trial set for December 14, 2026.
• · Medallion's board elevated Andrew Murstein to CEO, citing his 30 years as President and role in the company's growth.

02-06-2026

Plains GP Holdings, L.P. announced the promotion of Russ Montgomery to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, and the retirement of Chris Herbold as Senior Vice President, Finance and Chief Accounting Officer effective August 31, 2026.

• · Russ Montgomery, 50, previously served as Vice President, Controller of PAA since 2019.
• · Montgomery joined PAA in September 2002 and spent four years at Arthur Andersen LLP prior.
• · Chris Herbold's retirement is effective August 31, 2026, and Montgomery's promotion is effective September 1, 2026.

02-06-2026

On June 2, 2026, Philip Morris International Inc. (PMI) furnished an 8-K filing announcing that CEO Jacek Olczak hosted a live webcast and Q&A at the 2026 dbAccess Global Consumer Conference. The filing attaches a press release (Exhibit 99.1) with the company's remarks, but no specific financial data or performance figures were disclosed in the 8-K itself. The filing is a Regulation FD disclosure and contains no quantitative metrics or period-over-period comparisons.

• · The webcast and Q&A session occurred at the 2026 dbAccess Global Consumer Conference.
• · The press release is furnished under Item 7.01 and is not deemed 'filed' for SEC liability purposes.
• · The filing lists 21 series of notes and common stock traded on NYSE, ranging from 0.125% Notes due 2026 to 4.250% Notes due 2044.

02-06-2026

Plains All American Pipeline, L.P. (PAA) announced on June 1, 2026, that Russ Montgomery will be promoted to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, succeeding Chris Herbold, who is retiring on August 31, 2026. Montgomery has served as Vice President, Controller since 2019 and has been with the company since 2002.

• · Russ Montgomery, age 50, has been with PAA since September 2002, previously serving as Vice President, Controller (2019–present), Controller (2010–2019), Director of Operational Accounting (2008–2010), Manager of Crude Oil Accounting (2005–2008), and SEC and Financial Reporting Senior Analyst (2002–2005).
• · Prior to joining PAA, Montgomery spent four years at Arthur Andersen LLP.
• · Chris Herbold is retiring effective August 31, 2026.

02-06-2026

Hims & Hers Health, Inc. completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. The acquisition extends the company's leadership across Australia, Canada, Germany, Japan, and the United Kingdom, building on prior acquisitions of ZAVA and Livewell. The company reaffirmed its long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030, but faces integration risks and uncertainties related to international expansion and achieving these financial goals.

• · The acquisition closed pursuant to the terms of the definitive agreement.
• · Eucalyptus has served more than 850,000 customers to date (as of May 2026).
• · Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan.
• · The company can now reach hundreds of millions of people across four continents.
• · The press release includes cautionary language about forward-looking statements, highlighting risks related to integration, international expansion, regulatory compliance, customer adoption, and achieving long-term financial targets.

02-06-2026

On June 2, 2026, Genco Shipping & Trading Limited entered into the Third Amendment to its Shareholder Rights Agreement, eliminating the defined term 'Acting in Concert' based on shareholder feedback and board assessment. The amendment does not alter other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), and the Rights Agreement remains substantially similar to those of other public companies, intended to protect shareholder long-term value and prevent coercive control without a premium.

• · The Third Amendment was entered into on June 2, 2026.
• · The amendment eliminates the defined term 'Acting in Concert' from the Rights Agreement.
• · Other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), remain unchanged.
• · The Rights Agreement was originally dated October 1, 2025.
• · The amendment is intended to enable all shareholders to realize long-term value and provide the Board sufficient time to fulfill fiduciary duties.

02-06-2026

Hallador Energy acquired approximately 460 MW of Siemens gas turbines and related equipment for $350 million ($760/kW), with an additional $100 million in transportation/refurbishment/logistics costs, to accelerate its Merom natural gas project in MISO Zone 6. The acquisition secures long-lead-time equipment at an attractive valuation, and the project is targeted to begin generating revenue between late 2028 and mid-2029. The company had no outstanding bank debt as of March 31, 2026, maintains a $120 million credit facility, and has a contracted sales book of over $2.1 billion, including a previously announced 12-year capacity agreement valued at over $1 billion. However, the project remains subject to multiple milestones (MISO ERAS study completion by September 2026, GIA receipt, financing, offtake agreements, permits) and Hallador retains the option to sell the equipment or project rather than develop it.

• · The turbines have never been previously fired and are being acquired at what the company believes to be an attractive valuation compared to new equipment alternatives given current delivery windows.
• · The $450 million delivered price represents more than half the estimated total project cost for the Merom simple cycle project.
• · Hallador had no outstanding bank debt as of March 31, 2026.
• · The MISO ERAS study is anticipated to be completed in September 2026, after which Hallador will make a final investment decision.
• · Hallador retains optionality to: advance the full project, sell the project with equipment, or sell the equipment on a standalone basis.
• · The acquisition secures critical long-lead-time equipment in a market with significant supply constraints and extended lead times for new turbine deployment.

02-06-2026

BlockchAIn Digital Infrastructure, Inc. filed an S-1 registration statement with the SEC on June 2, 2026, for its initial public offering. The company, which focuses on digital infrastructure and AI data centers, reported a net loss of $41.9 million for the year ended December 31, 2025, compared to a net loss of $8.5 million for the successor period from February 8 to December 31, 2024, reflecting a significant increase in losses. Revenue grew to $5.0 million in 2025 from $0.9 million in the prior successor period, but the company remains unprofitable with an accumulated deficit of $53.5 million as of March 31, 2026.

• · The company's accumulated deficit was $53.5 million as of March 31, 2026.
• · Revenue for the three months ended March 31, 2026, was not separately disclosed in the provided excerpt.
• · The company has a history of losses and expects to continue incurring losses.
• · Jerry Tang has served as CEO since April 11, 2025, and also leads One BlockchAIn and TigerDC.
• · Jolienne Halisky was appointed CFO on March 16, 2026.
• · The filing includes financial data for both the predecessor (pre-February 8, 2024) and successor (post-February 8, 2024) periods due to a corporate reorganization.

02-06-2026

US Elemental Inc. filed an S-4 registration statement on June 2, 2026, in connection with a proposed business combination with Constellation Acquisition Corp. I (CSTA), a SPAC, and HiTech Minerals Inc., a wholly-owned subsidiary of Jindalee Lithium Limited. The transaction, valued at an equity value of $500 million, will result in HiTech (owner of the McDermitt Lithium Project) becoming a wholly-owned subsidiary of US Elemental, with US Elemental becoming a public company listed on Nasdaq under the symbol 'ULIT'. The filing includes three shareholder proposals: approval of the business combination, approval of the merger plan, and an adjournment proposal, with a minimum cash condition of $14 million required for closing.

• · The business combination agreement was entered into on April 9, 2026.
• · CSTA units will be detached into one Class A ordinary share and one-third of a CSTA warrant upon closing.
• · CSTA Class B ordinary shares will automatically convert into Class A ordinary shares before the exchange.
• · US Elemental intends to list on Nasdaq under symbols 'ULIT' (common stock) and 'ULITW' (warrants).
• · CSTA ordinary shares and warrants currently trade on OTCQB Basic Market under symbols 'CSTAF' and 'CSTWF'.
• · The minimum cash condition includes cash from PIPE Financing, trust account amounts (minus redemptions and taxes), minus CSTA transaction expenses.
• · The filing is preliminary and subject to completion, dated June 1, 2026.

02-06-2026

This DEFA14A filing announces that Taylor Morrison Home Corporation is being acquired by Berkshire Hathaway Inc. The filing is a solicitation communication related to the proposed acquisition and directs shareholders to review the upcoming proxy statement for details. No specific financial terms of the acquisition are disclosed in this filing.

• · The filing is a DEFA14A (additional proxy material) related to the proposed acquisition.
• · Taylor Morrison plans to file one or more proxy statements with the SEC in connection with the transaction.
• · The proxy statement for the 2026 annual meeting was filed on April 10, 2026.
• · Shareholders can obtain free copies of documents via SEC website or Taylor Morrison's investor relations page.
• · Contact: Taylor Morrison Home Corporation Investor Relations, 4900 N. Scottsdale Road, Suite 2000, Scottsdale, AZ 85251, investor@taylormorrison.com.

02-06-2026

NexMetals Mining Corp. issued a press release on June 1, 2026, reporting visual results from its ongoing 30,000-metre surface drilling program targeting the emerging Flexure Zone at the Selebi Main deposit in Botswana. The disclosure includes cautionary statements about mineral resource estimates under NI 43-101, emphasizing the uncertainty and that no assurance can be given that inferred or indicated resources will become economically mineable reserves.

• · The drilling program is targeting the emerging Flexure Zone at the Selebi Main deposit in Botswana.
• · The press release was furnished under Regulation FD and is not deemed filed under the Exchange Act.
• · Resource estimates use Canadian NI 43-101 standards, which differ from SEC S-K 1300 rules; investors are cautioned that indicated and inferred resources may not become economically mineable.

02-06-2026

AdaptHealth Corp. filed an amendment to its May 5, 2026 Form 8-K to correct the Date of Report to May 4, 2026, and to disclose material compensation changes for Daniel McFadden, who was appointed Chief Operating Officer effective May 4, 2026. The Compensation Committee approved an increase in his annual base salary from $410,000 to $550,000 (retroactive to the appointment date) and a one-time grant of restricted stock units valued at $464,110, with half vesting over three years and half tied to relative TSR performance. No negative or flat performance metrics were reported.

• · The original filing incorrectly reported the Date of Report as May 5, 2026; corrected to May 4, 2026.
• · The RSU grant is under the Second Amended and Restated 2019 Stock Incentive Plan.
• · The TSR-based portion of the RSUs uses a three-year performance period beginning February 1, 2026.
• · The amendment does not change any other information in the original filing.

02-06-2026

Plus Therapeutics filed an S-3 registration statement for a shelf offering of securities, allowing the company to raise capital for general corporate purposes including R&D, clinical trials, and commercialization. The filing highlights a net loss of $22.4M in 2025 (up from $13.0M in 2024) and a 1-for-25 reverse stock split in April 2026. The company is advancing its radiopharmaceutical pipeline and CNSide diagnostic test, with national payer agreements covering approximately 81 million lives.

• · The S-3 registration statement was filed on June 1, 2026, and became effective on June 2, 2026.
• · The company moved its headquarters to Houston, Texas in March 2025.
• · The CNSide Test laboratory in Houston received CLIA accreditation from CMS.
• · The reverse stock split was 1-for-25, effective April 2, 2026.
• · Net loss per share (basic, as adjusted for reverse split) was $(7.25) for 2025 and $(48.75) for 2024.
• · Common shares outstanding at year-end 2025 (as reported) were 138,675,856; as adjusted for reverse split: 5,547,034.

02-06-2026

NCS Multistage Holdings, Inc. has entered into a definitive merger agreement with Weatherford International plc, under which Weatherford will acquire NCS in an all-stock and mixed consideration transaction expected to close in the second half of 2026. Holders of more than 50% of NCS common stock have already consented to the merger, eliminating the need for further stockholder approval.

• · The Merger Agreement includes a no-shop clause and provisions for superior proposals.
• · NCS restricted stock units (RSUs) and equivalent stock units (ESUs) will be assumed by Weatherford, with terms continuing including vesting, but the Max Value Cap on ESUs will cease.
• · NCS performance stock units (PSUs) will be assumed with performance goals deemed satisfied at the greater of target and actual level as of the Merger Agreement date.
• · NCS options with an exercise price less than the value of the Share Consideration will be assumed and converted; those with an exercise price equal to or greater will be cancelled without consideration.
• · Non-employee director NCS DSUs will automatically vest and settle in NCS common stock immediately prior to the Effective Time.
• · The Outside Date for closing is May 31, 2027, after which either party may terminate if the merger has not been completed.
• · The Merger is subject to customary closing conditions including regulatory approvals, effectiveness of an S-4 registration statement, and no Material Adverse Effect.

02-06-2026

Honeywell appointed Jillian Evanko, CEO of Duravant, to its Board as an Independent Director and Audit Committee member, effective immediately. The appointment comes ahead of the planned spin-off of Honeywell's Aerospace business on June 29, 2026, after which several directors will move to the Aerospace board. Evanko brings over 25 years of industrial and manufacturing experience, including as former CEO of Chart Industries.

• · Evanko, 48, has more than 25 years of experience across industrial and manufacturing sectors.
• · She spent nearly a decade at Chart Industries, most recently as President and CEO and prior as CFO.
• · She holds an MBA from The University of Notre Dame and a BS in Business Administration from La Salle University.
• · Following the Aerospace spin-off on June 29, 2026, Craig Arnold, Bill Ayer, Scott Davis, and Deborah Flint will join the Honeywell Aerospace board.
• · Evanko currently serves as an independent director of Greif, Inc. and previously served on boards of Chart Industries, Parker Hannifin, and Alliant Energy.

02-06-2026

News Corp filed an 8-K on June 2, 2026, disclosing its ongoing stock repurchase program, under which it is authorized to buy back up to $1 billion in aggregate of its Class A and Class B common stock. The filing includes daily transaction disclosures provided to the Australian Securities Exchange (ASX) as required by ASX rules. The company also included forward-looking statements regarding its intent to repurchase shares from time to time.

• · The repurchase program covers both Class A common stock (ticker NWSA) and Class B common stock (ticker NWS), both listed on the Nasdaq Global Select Market.
• · The company is required to provide daily transaction disclosures to the ASX under ASX rules.
• · The filing includes forward-looking statements subject to risks such as changes in market price, general market conditions, securities laws, and alternative investment opportunities.

02-06-2026

Lantern Pharma Inc. filed an 8-K on June 1, 2026, disclosing a presentation used in discussions regarding the Harmonic™ Phase 2 clinical trial for its product candidate LP-300. The presentation is furnished as Exhibit 99.1 but is not deemed filed for SEC liability purposes. No financial results or material changes were reported.

• · The 8-K was filed under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The presentation is not incorporated by reference into any SEC filings unless expressly stated.
• · The company's common stock trades on Nasdaq under the symbol LTRN.

02-06-2026

U.S. Global Investors, Inc. (GROW) announced on May 29, 2026 that its previously issued financial statements for the three and nine months ended March 31, 2026 should no longer be relied upon due to an error in the calculation of weighted-average shares outstanding, which overstated basic and diluted EPS by $0.02 and $0.01, respectively. The error did not affect revenues, expenses, net income, cash flows, or financial position, and the company plans to file an amended Form 10-Q/A to restate the affected disclosures. Management identified a material weakness in internal control over financial reporting related to the error and is implementing remedial measures.

• · The error was caused by a formula omission in a supporting spreadsheet that excluded a component of shares from the summation used to calculate weighted-average shares.
• · The error did not impact revenues, expenses, net income (loss), cash flows, financial position, or shares outstanding at period end.
• · Management concluded a material weakness existed in internal control over financial reporting as of March 31, 2026, related to a failure in the operation of a review control over the weighted average shares outstanding calculation.
• · The Audit Committee discussed the matters with Grant Thornton LLP, the company's independent registered public accounting firm.
• · The company issued a press release on June 1, 2026, announcing the intent to restate EPS for the March 31, 2026 financial statements.

02-06-2026

Tempest Therapeutics entered into a warrant exercise and inducement agreement on May 28, 2026, resulting in approximately $2.0 million in gross proceeds from the cash exercise of existing warrants at a reduced price of $1.73 per share. The company issued new warrants to purchase up to 2,344,828 shares at the same reduced price, along with placement agent warrants. The transaction provides immediate cash but significantly dilutes existing shareholders, and the new warrants are subject to stockholder approval before becoming exercisable.

• · Existing warrants were originally issued in November 2025 at an exercise price of $3.50 per share; reduced to $1.73 per share.
• · New warrant exercise price is $1.73 per share, expires May 29, 2028.
• · New warrant exercisable only after stockholder approval under Nasdaq rules.
• · Placement agent warrants have an exercise price of $2.1625 per share.
• · Company must file a resale registration statement within 30 days and use best efforts to have it effective within 45 days (75 days if SEC review).
• · Placement agent receives 7% cash fee and 7% warrant coverage on any future cash exercise of new warrants within 24 months of issuance.
• · Shares from existing warrants were registered under Form S-1 (File No. 333-292026); new warrants and placement agent warrants are unregistered.

02-06-2026

Fulgent Genetics announced on June 1, 2026, that it will present updated data from its FID-007 combination study with cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) at the ASCO 2026 Annual Meeting Rapid Oral Abstract Session. The abstract (#6020) was previously released on May 21, 2026. No financial figures or performance metrics were disclosed in this filing.

• · The presentation will be in the Head and Neck Cancer Track during the ASCO 2026 Annual Meeting Rapid Oral Abstract Session.
• · The abstract number is #6020.
• · The press release was issued on June 1, 2026, and is filed as Exhibit 99.1.

02-06-2026

Teleflex Incorporated priced a private offering of $500.0 million aggregate principal amount of 5.875% Senior Notes due 2032. The net proceeds, together with cash on hand, will be used to redeem all of its outstanding 4.625% Senior Notes due 2027. The offering is expected to close on or about June 15, 2026.

• · The new notes are being offered in a private transaction to qualified institutional buyers and non-U.S. persons.
• · The notes and related guarantees have not been registered under the Securities Act.
• · The press release is attached as Exhibit 99.1.

02-06-2026

NextTrip, Inc. (NTRP) filed an S-3/A registration statement with the SEC on June 1, 2026, to register securities for a proposed offering. The filing incorporates by reference several prior documents, including a Securities Purchase Agreement and Pledge Agreement dated May 7, 2026, and a Certificate of Amendment effective May 6, 2026. The registration statement was signed by CEO William Kerby on June 1, 2026.

• · Registration No. 333-296201 was originally filed on March 24, 2022.
• · The filing incorporates a Certificate of Amendment effective May 6, 2026 (Exhibit 3.7).
• · A Securities Purchase Agreement and Pledge Agreement were both dated May 7, 2026 (Exhibits 10.1 and 10.2).
• · The filing includes a consent from Haynie & Company (Exhibit 23.1).
• · The registration statement was signed in Santa Fe, New Mexico.

02-06-2026

General Fusion Inc., a fusion energy company, announced its leadership team will participate in three investor and industry conferences in June 2026 as it prepares to go public via a business combination with Spring Valley Acquisition Corp. III (SVAC). The company highlighted its LM26 fusion demonstration machine, which began operating in early 2025 and aims to achieve key fusion milestones. However, the filing contains extensive forward-looking statements cautioning about risks including potential failure to complete the business combination, inability to commercialize MTF technology, and capital raising uncertainties.

• · General Fusion was established in 2002 and is headquartered in Vancouver, Canada.
• · LM26 is the first MTF demonstration machine built at commercially relevant scale, mechanically compressing plasma with a lithium liner.
• · LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion.
• · Spring Valley I completed a business combination with NuScale Power; Spring Valley II with Eagle Nuclear Energy Corp.
• · The business combination agreement was dated January 21, 2026, and involves SVAC continuing from Cayman Islands to British Columbia, amalgamation with NewCo, and name change to General Fusion Group Ltd.
• · The filing includes a PIPE Financing risk regarding convertible preferred shares and warrants.

02-06-2026

SmartStop Self Storage REIT disclosed same-store metrics as of May 31, 2026. Physical occupancy declined to 92.4% from 93.1% year-over-year, while monthly web rates and move-in rates also decreased. However, monthly in-place rates increased to $1.66 from $1.63.

• · Same-store facilities exclude four other properties.
• · Stabilized and comparable properties included since January 1, 2025.

02-06-2026

At a reconvened Special Meeting on June 1, 2026, Functional Brands Inc. stockholders approved a reverse stock split (ratio range 1:2 to 1:250) and the 2026 Equity Incentive Plan. However, only 35.93% of eligible shares (7,874,310 out of 21,912,868) were represented, indicating low shareholder turnout, and the reverse stock split proposal saw significant opposition with 3,361,162 votes against.

• · The reverse stock split ratio can range from 1:2 to 1:250, with the exact ratio set by the Board without further stockholder approval.
• · The reverse stock split must be effected within one year of the Special Meeting (by June 1, 2027).
• · The 2026 Equity Incentive Plan received 4,613,683 FOR votes, 1,527,837 AGAINST, 58,670 abstentions, and 1,732,790 broker non-votes.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
• · The company's common stock trades on Nasdaq under the symbol MEHA.

02-06-2026

American Rebel Holdings Inc. filed a DEF 14A proxy statement detailing executive compensation, related-party transactions, and a proposal to ratify GBQ Partners LLC as independent auditor for FY2026. Key executive changes include Doug Grau stepping down as President and Interim Principal Accounting Officer on July 1, 2025, to lead a new subsidiary, American Rebel Productions, LLC. The filing also reveals significant related-party transactions, including an outstanding $400,000 director loan from Larry Sinks that remains unpaid as of December 31, 2025, and the issuance of Series D Convertible Preferred Stock to executives and directors to settle accrued bonuses and fees totaling over $2.0 million.

• · No named executive officers exercised stock options or had restricted stock units vest in FY2025 or FY2024.
• · No outstanding equity awards (unexercised options or unvested stock) were held by named executive officers as of December 31, 2025.
• · The company does not offer any annuity, pension, or retirement benefits to officers, directors, or employees.
• · Director Larry Sinks received $36,000 in consulting fees in addition to his director compensation.
• · The company leases facilities from entities owned by former Champion founder Mr. Crosby, believed to be at or below market rate.
• · As of January 1, 2025, Messrs. Ross, Lambrecht, and Grau each vested conversion rights in 10,000 additional shares of Series A Preferred Stock, convertible into 5,000,000 shares of common stock each.
• · Ross and Lambrecht each hold additional 26,250 and 6,250 shares of Series A Preferred respectively, convertible annually starting January 1, 2026 at a rate of 500 to 1.

02-06-2026

OceanFirst Financial Corp. filed an S-3 registration statement with the SEC on June 1, 2026, registering up to 22,773,278 shares of common stock for resale by selling securityholders. The company will not receive any proceeds from the sale, and as of May 26, 2026, there were 57,600,069 shares outstanding. The filing includes standard risk factors and forward-looking statements, with no new financial results or operational updates.

• · The company's authorized capital stock consists of 150,000,000 shares of common stock and 5,000,000 shares of preferred stock, each with $0.01 par value.
• · As of May 26, 2026, there were 63,329,377 shares issued and 5,729,308 shares held in treasury.
• · Outstanding stock options total 1,160,665 shares; additional 644,539 stock awards and 1,611,347 stock options are reserved for issuance.
• · Common stock is listed on NASDAQ Global Select Market under symbol OCFC.
• · Holders of more than 10% of outstanding common stock are not entitled to vote shares in excess of that limit.
• · Certain matters require an 80% stockholder vote, calculated after applying the 10% voting cap.
• · Stockholders are not permitted to act by written consent.
• · The company will bear all costs of registration except underwriting discounts and commissions.

02-06-2026

Fundrise eREIT, LLC declared a June 2026 daily distribution of ~$0.00006849 per share, equating to an annualized return of approximately 0.25%. No prior period comparisons or other performance metrics are provided, making it impossible to assess changes in distribution rates.

• · Distributions are payable for each calendar day in the period from June 1, 2026 to June 30, 2026.
• · Shareholders of record as of the close of business on each day of the June 2026 Distribution Period are eligible.
• · Payments are scheduled to be made prior to July 21, 2026.
• · The Manager (Fundrise Advisors, LLC) is under no obligation to declare future distributions at the same rate.
• · The filing includes a cautionary statement regarding forward-looking risks as detailed in the Prospectus filed April 27, 2026.

02-06-2026

TXNM Energy's subsidiaries filed two key regulatory actions on May 29, 2026: TNMP filed a comprehensive settlement in its base rate review with the PUCT, and PNM filed an application with the NMPRC to advance carbon-free generation resources. The filings are disclosed under Regulation FD and Item 8.01, with no financial figures or performance metrics provided in the 8-K.

• · TNMP's base rate review settlement was filed with the Public Utility Commission of Texas (PUCT) on May 29, 2026.
• · PNM's application for carbon-free generation resources was filed with the New Mexico Public Regulatory Commission (NMPRC) on May 29, 2026.
• · The press releases are furnished as Exhibits 99.1 and 99.2 and are not deemed filed under the Exchange Act.

02-06-2026

Breeze Acquisition Corp. II completed its initial public offering (IPO) of 14,000,000 units (including partial exercise of the over-allotment option) at $10.00 per unit, generating gross proceeds of $140,000,000, and simultaneously sold 470,000 private placement units to Breeze Sponsor II, LLC for $4,700,000. A total of $144,700,000 was placed in a trust account. However, the auditor's report includes a going concern explanatory paragraph noting substantial doubt about the Company's ability to continue as a going concern, as it has no approved plan to extend the business combination deadline beyond May 14, 2027 and lacks capital resources to fund operations and complete a business combination.

• · The Company was incorporated in the Cayman Islands on August 20, 2025 and had not commenced any operations as of May 14, 2026.
• · Transaction costs totaled $5,710,654, including $1,562,500 in cash underwriting fees and $3,729,654 in other offering costs.
• · The Company has until May 14, 2027 to complete a business combination, with no approved plan to extend the deadline.
• · The auditor, CBIZ CPAs P.C., has served as the Company's auditor since 2025.
• · The balance sheet shows total assets of $126,393,403, total liabilities of $2,581,609, and shareholders' deficit of $1,500,706.

02-06-2026

Venture Global, Inc. announced that its subsidiary, Venture Global LNG, Inc., has launched and priced a private offering of $1.125 billion in 2034 senior secured notes and $1.125 billion in 2036 senior secured notes, totaling $2.25 billion. The proceeds will be used to redeem all outstanding 8.125% senior secured notes due 2028 at a redemption price of 102.031% of principal plus accrued interest, with cash on hand covering the premium and fees. The redemption is conditional on the closing of the notes offering and is expected to occur on June 11, 2026. The filing also includes forward-looking statements highlighting risks such as potential inability to maintain profitability, need for additional capital, and ongoing legal disputes.

• · The redemption is conditioned upon the closing of the Notes Offering generating sufficient gross proceeds no less than the aggregate principal amount of the Existing Notes to be redeemed.
• · The Existing Notes were issued under an Indenture dated May 26, 2023.
• · The Notes are being offered only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S.
• · The filing includes forward-looking statements with risks such as potential inability to maintain profitability, need for additional capital, and ongoing legal disputes.

02-06-2026

Donaldson reported record third quarter fiscal 2026 sales of $995.1M, up 5.8% YoY, and GAAP EPS of $1.00 (up 108.2% from $0.48), driven by strong Mobile Solutions (+8.1%) and Life Sciences (+12.7%) segment growth. However, Industrial Solutions sales declined 0.6% YoY, with Aerospace and Defense down 13.5%, and gross margin contracted to 33.5% from 34.2%. The company completed the $829M acquisition of Facet Filtration on May 4, 2026, and narrowed its fiscal 2026 organic sales growth guidance to 3%-5% (from 1%-5% previously), while lowering adjusted operating margin guidance to 15.8%-16.2% (from 16.0%-16.4%).

• · Third quarter GAAP net earnings of $118.1M vs $57.8M a year ago, a 104.4% increase.
• · Adjusted net earnings of $125.5M vs $118.9M in Q3 FY25.
• · GAAP diluted EPS of $1.00 vs $0.48; adjusted diluted EPS of $1.06 vs $0.99.
• · Gross margin declined to 33.5% from 34.2% due to operating inefficiencies in Power Generation.
• · Adjusted gross margin was 34.4%, down 10 bps YoY.
• · Operating expenses as % of sales improved to 17.9% from 24.9% (GAAP); adjusted to 17.8% from 18.2%.
• · Interest expense increased to $6.5M from $5.7M due to higher debt levels.
• · Effective tax rate improved to 23.7% from 33.6% (GAAP); adjusted rate increased to 23.8% from 22.1%.
• · Year-to-date dividends paid: $104.0M; share repurchases: $108.5M (1.2% of shares outstanding).
• · Facet acquisition closed on May 4, 2026 for $829M all-cash; results reported in Industrial Solutions from Q4.
• · Fiscal 2026 organic sales guidance narrowed to 3%-5% growth (from 1%-5%).
• · Adjusted operating margin guidance lowered to 15.8%-16.2% (from 16.0%-16.4%).
• · Adjusted EPS guidance (organic) raised to $3.94-$4.01 (7%-9% growth vs prior $3.68).
• · Facet expected to contribute $25M-$30M in sales and $0.03 EPS dilution in FY26.
• · Capital expenditures forecast $60M-$75M; adjusted free cash flow conversion 85%-95%.
• · Full-year share repurchases expected to remain at 1.2% of shares outstanding.
• · On-Road sales for nine months declined 11.4% (reported) and 12.7% (constant currency).
• · Aerospace and Defense sales declined 13.5% in Q3 due to supply chain constraints and project timing.
• · Industrial Filtration Solutions constant currency growth was only 0.2% in Q3 (essentially flat).

02-06-2026

BurTech Acquisition Corp II completed its initial public offering (IPO) of 8,000,000 units at $10.00 per unit, generating gross proceeds of $80,000,000, and a simultaneous private placement of 252,000 units at $10.00 per unit for $2,520,000. A total of $80,400,000 was deposited into a trust account for public shareholders. However, the company's auditor has raised substantial doubt about its ability to continue as a going concern due to insufficient cash and working capital to sustain operations for one year.

• · The company has not yet commenced operations and will not generate operating revenues prior to a business combination.
• · Transaction costs totaled $1,386,506, including an $800,000 underwriting fee.
• · The trust account holds $80,400,000 ($10.05 per unit) invested in U.S. government securities or money market funds.
• · The company must complete a business combination with a target having a fair market value of at least 80% of trust assets.
• · The company's auditor, WithumSmith+Brown, PC, has been the auditor since 2025.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

02-06-2026

This 8-K filing reports a Seventh Addendum to the Sixth Amended and Restated Service Agreement between Comenity Bank and Comenity Servicing LLC, effective June 1, 2026. The addendum modifies certain services and performance standards related to issues management, including amended service descriptions and new performance metrics (e.g., closing 90% of issues within 250 days, completing 90% of Level 3 consumer containment/remediation within 210 days), while deleting previous containment standards. No financial amounts or quantitative financial data are disclosed in the filing.

• · The addendum amends Appendix A (Services) and Appendix B (Performance Standards) of the existing Sixth Amended and Restated Service Agreement dated January 1, 2025.
• · Previous performance standards for containing non-technical and technology/system-dependent issues impacting customers were deleted.
• · The agreement continues in full force and effect except as amended by this addendum.

02-06-2026

BRC Inc. held its 2026 Annual Meeting on May 28, 2026, where stockholders elected three Class I directors (Kathryn Dickson, Chris Mondzelewski, and Lawrence 'Chip' Molloy) and ratified Ernst & Young LLP as independent auditor for FY2026. Stockholders also approved a reverse stock split of Class A common stock at a ratio between 1-for-10 and 1-for-50, with the Board retaining discretion to abandon the amendment. However, the reverse stock split proposal received only 78,970,591 votes in favor versus 7,235,842 against, indicating notable shareholder opposition, and the company issued a press release on June 2, 2026, regarding these matters.

• · The reverse stock split proposal was approved with 78,970,591 votes in favor and 7,235,842 against, representing about 91.6% of votes cast in favor, but only Class A stockholders voted on this proposal.
• · The adjournment proposal was approved with 139,678,169 votes in favor and 6,148,870 against.
• · The company issued a press release on June 2, 2026, attached as Exhibit 99.1, which is incorporated by reference but not filed for Section 18 purposes.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

02-06-2026

HIVE Digital Technologies reported FY2026 total revenue of $297.8 million, up 158% YoY, driven by a 164% surge in digital currency mining revenue to $278.3 million and a 94% increase in HPC revenue to $19.5 million. However, the company posted a GAAP net loss of $148.4 million, largely due to $221.3 million in non-cash charges, and Q4 FY2026 adjusted EBITDA turned negative at ($9.0) million amid hashprice compression and rising network difficulty. Despite strong annual growth, sequential Q4 Bitcoin mining revenue declined 23.9% from Q3 FY2026.

• · FY2026 average Bitcoin price was $98,040 vs $75,881 in FY2025.
• · Q4 FY2026 average Bitcoin price was $76,476, down approximately 27% from Q3 FY2026 average of ~$98,000.
• · Average network difficulty increased from 95.7T in FY2025 to 135.8T in FY2026 (42% increase).
• · Q4 FY2026 average network difficulty was 140.7T, up 27% YoY from 111.2T.
• · HPC gross margin expanded to approximately 40% in FY2026.
• · Non-cash items in FY2026 net loss: $170.4M depreciation, $50.9M net non-cash adjustments.
• · Non-cash items in Q4 FY2026 net loss: $52.7M depreciation, $30.6M non-cash adjustments.
• · Cash from operations increased 3.5-fold to $62.3M in FY2026.
• · GTA Gigafactory site: 25 acres in Toronto-Waterloo innovation corridor, targeted online in H2 2027.
• · GTA Gigafactory designed for sub-1.3 PUE with closed-loop liquid cooling, no water use.
• · Bell B200 cluster pricing: $2.90 per GPU-hour, 32% above planning rate of $2.20.
• · HIVE up-listed to TSX senior board on May 19, 2026.
• · Notes offering: $115M 0% Exchangeable Senior Notes due 2031, exchangeable at ~$2.57 per share, capped call at ~$4.92 per share.
• · HIVE's BTC-per-EH/s production ranked top among miners per Power Mining Analysis.
• · BUZZ Cloud ranked fastest download speeds per SemiAnalysis ClusterMAX 2.0.

02-06-2026

Firefly Aerospace Inc. priced a follow-on public offering of 12,000,000 shares of common stock at $48.00 per share, with an additional 1,800,000 shares available to underwriters. The offering closed on June 1, 2026, and includes both primary shares from the company and secondary shares from selling stockholders.

• · The offering was priced on May 28, 2026 and closed on June 1, 2026.
• · Underwriters have a 30-day option to purchase up to an additional 1,800,000 shares.
• · The Underwriting Agreement includes customary representations, warranties, and indemnification provisions.

02-06-2026

The Brink's Company filed an 8-K on June 2, 2026, disclosing that it updated its investor and analyst slide presentation. The company reiterated its previously disclosed guidance in connection with the updated slides. No new financial figures or changes to prior guidance were provided.

• · The filing is a Regulation FD Disclosure under Item 7.01.
• · The updated slide presentation is furnished as Exhibit 99.1.
• · The information is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

02-06-2026

FS KKR Capital Corp. filed an 8-K on June 2, 2026, to furnish a press release under Regulation FD. The filing does not contain any financial results or material operational updates, only the press release attached as Exhibit 99.1.

• · The press release was issued on June 2, 2026, and is attached as Exhibit 99.1.
• · The filing is a Regulation FD disclosure and is not deemed 'filed' with the SEC.